Viewing StudyNCT03837353



Ignite Creation Date: 2024-05-06 @ 12:43 PM
Last Modification Date: 2024-10-26 @ 1:03 PM
Study NCT ID: NCT03837353
Status: TERMINATED
Last Update Posted: 2023-12-18
First Post: 2019-01-22

Brief Title: A Parallel Arm Phase 1b2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1
Sponsor: NYU Langone Health
Organization: NYU Langone Health

Organization Data

Organization: NYU Langone Health
Class: OTHER
Study ID: 17-01747
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NYU Langone Health
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Leap Therapeutics Inc INDUSTRY